What the Prostate Cancer Foundation does for patients

The Prostate Cancer Foundation, usually shortened to PCF, calls itself the world's leading philanthropic organization dedicated to funding prostate cancer research. It was started in 1993 by Mike Milken, a financier who had just been diagnosed with prostate cancer himself and wanted to speed up the science.

That origin still shapes what PCF is today. It is not a hospital and not a government agency. It is a charity that raises money and gives it to scientists.

PCF reports having raised more than $1 billion and funded over 2,615 research projects at 312 cancer centers across 29 countries. It runs several named grant programs, including Young Investigator Awards for early-career scientists, Challenge Awards, TACTICAL Awards, and larger multi-institution Dream Teams.

One specific program stands out for veterans. PCF has helped establish 21 PCF-VA precision oncology Centers of Excellence in partnership with the Department of Veterans Affairs, aimed at bringing newer prostate cancer science into VA care.

Even though PCF's main job is funding research, its website is built for patients too. It publishes free material on screening, diagnosis, treatment choices, and the side effects that come with them.

Specific things you can use right away include:

• Patient guides written for people who are not clinicians
• A clinical trial finder to search for studies that might fit
• Listings of support groups and recorded webinars
• General financial support information
• Mental health and wellness resources
• Spanish-language material for patients and families

None of this requires an appointment or a referral. It is published on pcf.org for anyone to read.

PCF does not treat patients. It has no clinics, no doctors seeing you in person, and no role in choosing your treatment plan. That decision stays between you and your own care team.

It also does not run its own copay or grant program the way some disease-specific charities do. Its site lists financial support information, but that is a guide to other resources, not a guaranteed check from PCF itself.

And using the clinical trial finder does not enroll you in anything. It is a search tool. Each trial has its own eligibility criteria decided by the research team running it, and PCF has no say in whether you personally qualify.

It is easy to skip past the research-funding language and go straight to the patient guides. But the two are connected. Many of the newer prostate cancer tests and drugs your doctor might mention started as PCF-funded projects at a university lab.

Knowing that does not change your treatment choice today. It is useful mainly as context: when a patient guide from PCF references newer science, that science often traces back to work the foundation itself helped pay for.

Prostate cancer information is dense, and PCF's site covers everything from active surveillance to advanced disease. Pick your entry point by where you are.

If you are newly diagnosed, start with the basic screening and diagnosis guides before anything else. If you are already in treatment, the side-effect and support group pages are more useful. If you are looking for options beyond standard care, the clinical trial finder is the right tool, but treat its results as a starting list for a conversation with your oncologist, not a menu to choose from alone.

PCF's programs, award names, and contact details can change as the organization grows. Phone numbers, application windows for grants, and which resources are free versus limited can shift year to year.

So treat anything specific here, including phone numbers or named programs, as a starting point. Check the current details on their site before you plan around them, and ask your own care team whether a PCF resource fits your particular situation before relying on it.

PCF's recorded webinars and support group listings are easy to overlook next to the research statistics, but they are often the most practical part of the site for a patient right now. A webinar on managing hormone therapy side effects, for instance, can answer a question you have been saving for your next appointment.

If you are choosing between reading a guide and joining a live session, consider your situation. A guide works well when you want a quick answer. A support group or live webinar works better when you want to hear how other patients actually handled a decision, or when you want to ask a question out loud instead of typing it into a search box.